Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
06/2010
06/23/2010CN101020015B Externally applied medicine for treating chronic prostatitis and prostatic hyperplasia
06/22/2010US7741452 produced by introducing amino acid mutation(s) so that no glycosylation take place at at least one glycosylation site of hepatocyte growth factor; more stable in the blood circulation
06/22/2010US7741434 High-affinity antagonists of ELR-CXC chemokines
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7740842 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease
06/22/2010US7740831 Compositions for potentiating glutathione
06/22/2010CA2586538C Nitroxy steroids
06/22/2010CA2523253C Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2444489C Benzimidazolone compounds
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2443938C Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
06/22/2010CA2443633C Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
06/22/2010CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens
06/22/2010CA2401655C Cardioprotective phosphonates and malonates
06/22/2010CA2190943C Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
06/17/2010WO2010068863A2 Pyrimidine compounds and methods of making and using same
06/17/2010WO2010068287A2 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
06/17/2010WO2010067204A1 Highly pure cinacalcet or a pharmaceutically acceptable salt thereof
06/17/2010WO2010066629A2 Novel azaindoles
06/17/2010WO2010066125A1 A short peptide, preparation and uses thereof
06/17/2010WO2010066028A1 3,4 - substituted piperidine derivatives as renin inhibitors
06/17/2010WO2010025135A3 Trimeprazine and ethopropazine derivatives for promoting bone growth
06/17/2010WO2009101059A3 Methods of using cadherin 11 (cdh11) antagonists
06/17/2010US20100152442 4-anilino quinazoline derivatives as antiproliferative agents
06/17/2010US20100152305 Methods of treatment of hyperuricemia and associated disease states
06/17/2010US20100152285 Flavononol Renin Inhibitor Compounds and Methods of Use Thereof
06/17/2010US20100152281 Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function
06/17/2010US20100152269 Modified-release formulations of azabicyclo derivatives
06/17/2010US20100152265 Indazole derivatives
06/17/2010US20100152263 Therapy for the treatment of disease
06/17/2010US20100152261 Novel nitrogen-containing heterocyclic compound
06/17/2010US20100152257 Antagonists of lysophosphatidic acid receptors
06/17/2010US20100152252 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
06/17/2010US20100152210 Purinyl derivatives and their use as potassium channel modulators
06/17/2010US20100152203 Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonists
06/17/2010US20100152186 Triazolyl pyridyl benzenesulfonamides
06/17/2010US20100152180 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152151 Tgr5 modulators and methods of use therof
06/17/2010US20100152113 Metal-binding therapeutic peptides
06/17/2010US20100151063 Serum uric acid level-decreasing agent and food and drink with label telling that food and drink decrease serum uric acid level
06/17/2010US20100151034 Granular pharmaceutical composition of atorvastatin for oral administration
06/17/2010US20100151027 Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
06/17/2010US20100150893 Methods of organ regeneration
06/17/2010CA2747279A1 3,4 - substituted piperidine derivatives as renin inhibitors
06/16/2010EP2196218A2 Use of anti-TNFalpha antibodies and another drug
06/16/2010EP2196213A1 Immunogenic LHRH compositions and methods relating thereto
06/16/2010EP2196201A2 Combination of an alpha-2-delta ligand with a pdev inhibitor or a muscarinic antagonist to treat lower urinary tract symptoms
06/16/2010EP2194988A2 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis
06/16/2010EP2194984A1 Medicament for treating or preventing proteinuria
06/16/2010EP1809271B1 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
06/16/2010EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine
06/16/2010EP1436281B1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/16/2010CN1902165B Synthesis of optically pure (R)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide
06/16/2010CN1889969B Application of herbal compositions in preparation of medicine for treating prostate cancer
06/16/2010CN1886141B T-type calcium channel inhibitor
06/16/2010CN1837226B Separation of medical derivatives from phoenix-tail fern and use thereof
06/16/2010CN1830978B Pyrazolo [4,3-c]-quinolin-3-one compound, preparation method and use thereof
06/16/2010CN1500095B Polymer conjugates of neublastin and methods of using ssame
06/16/2010CN101735991A Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
06/16/2010CN101735918A Selenium-rich health wine and production method thereof
06/16/2010CN101735306A Anti-inflammatory peptide with membrane penetration effect
06/16/2010CN101732700A Health-care wine and preparation method thereof
06/16/2010CN101732671A Chinese medicinal composition for treating chronic nephritis and preparation method thereof
06/16/2010CN101732668A Preparation method of Chinese medicinal composition for treating urinary system infection
06/16/2010CN101732660A Chinese medicinal preparation for treating prostate disease and preparation method thereof
06/16/2010CN101732646A Capsule for tonifying kidneys and nourishing brain
06/16/2010CN101732624A Formula for treating ureteral calculi and preparation method thereof
06/16/2010CN101732621A Chinese medicament for treating kidney stones
06/16/2010CN101732614A Chinese medicament for treating urinary tract infection
06/16/2010CN101732611A Chinese medicament for treating purpuric nephritis
06/16/2010CN101732603A Chinese medicinal decoction for treating urinary stone disease
06/16/2010CN101732602A Medicament for treating calculi and preparation method thereof
06/16/2010CN101732598A Chinese medicinal preparation for treating syndrome of nephritis and nephropathy
06/16/2010CN101732566A Traditional Chinese medicine compound preparation for tonifying liver and kidney and strengthening bones and muscles
06/16/2010CN101732563A Application of composite from trametes robinioplila murr, wolfberry and sealwort
06/16/2010CN101732562A Traditional Chinese medicine for tonifying kidneys, strengthening heart, dissipating blood stasis and activating collaterals
06/16/2010CN101732540A Method for determining effective component of total glycoside in smilax glabra ethanol water solution extract
06/16/2010CN101732534A Traditional Chinese medicine for tonifying kidney, producing sperm, supplementing qi and nourishing blood
06/16/2010CN101732443A Application of prince feather-containing composition in preparation of medicaments of treating kidney diseases
06/16/2010CN101732440A Raspberry extract and raspberry element obtain by separation thereof and application thereof
06/16/2010CN101732434A Method for inducing increase in varierty and content of secondary metabolite in clematis terniflora (medicinal plant)
06/16/2010CN101732421A Method for preparing total flavonoids, total tannins and galic acid compounds of polygonum capitatum
06/16/2010CN101732384A Extract for treating nephritis, and preparation method and use thereof
06/16/2010CN101732323A Application of low-dose ursolic acid as medicament for treating diabetic early nephropathy
06/16/2010CN101732305A Application of iridoid compounds in preparing medicament for treating benign prostatic hyperplasia
06/16/2010CN101732298A Treating benign prostate hyperplasia with sarms
06/16/2010CN101181575B Motherwort strip containing natural aromatic plant
06/16/2010CN101181468B Chinese medicine composition orally taken for curing cystitis
06/16/2010CN101155814B Crystals of morphinan derivative and process for producing the same
06/16/2010CN101120917B Compound amino acid injection composition suitable for kidney disease patient
06/16/2010CN101056627B Therapeutic agent for interstitial cystitis
06/16/2010CN101032586B Chinese traditional medicine composition to be taken orally for curing acute cystitis
06/16/2010CN101010323B Bicyclononene derivatives as renin inhibitors
06/16/2010CN101002625B Beverage for relieving summer heat, and its preparing process
06/15/2010US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
1 ... 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 ... 562